Articles tagged "Liver transplantation"

2022 American Transplant Congress
Sleeve Gastrectomy Reduces Need for Liver Transplantation for NASH Patients
R. A. Choudhury¹, A. Rouhi², G. Hoeltzel³, Y. Bababekov¹, A. Suarez-Pierre⁴, A. Yule¹, N. Vigneshwar⁴, N. Williams⁵, K. Dumon², J. Pomposelli¹, H. B. Moore¹, E. Pomfret¹, T. Nydam¹
¹Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ³General Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, ⁴Cardiothoracic Surgery, University of Colorado Hospital, Aurora, CO, ⁵General Surgery, Hospital of the University of Pennsylvania, Aurora, CO
*Purpose: Non-Alcoholic Steatohepatitis (NASH) is one of the leading indications for liver transplantation (LT) in the United States. As with the current obesity epidemic, the…
2022 American Transplant Congress
Social Determinants of Health and Biochemical Alcohol Relapse in Alcohol-Associated Liver Disease
K. Torosian¹, F. Delebecque², A. Liu², D. Arellano², S. Dave³, G. Schnickel⁴, V. Ajmera³
¹Internal Medicine, University of California San Diego Health, San Diego, CA, ²University of California San Diego, San Diego, CA, ³Transplant Hepatology, University of California San Diego Health, San Diego, CA, ⁴Transplant Surgery, University of California San Diego Health, San Diego, CA
*Purpose: Alcohol use after liver transplant is associated with higher rates of graft loss and increased mortality; however, there is limited data regarding the factors…
2022 American Transplant Congress
A Qualitative Comparison of Declined Hispanic and Non-Hispanic Living Liver Donor Candidates at a High-Volume Urban Transplant Center
D. Toy¹, B. Horwich¹, A. Mulgaonkar¹, A. Padilla², J. L. Dodge³, N. Kaur⁴, H. Han³
¹Department of Medicine, University of Southern California, Los Angeles, CA, ²USC Transplant Institute, University of Southern California, Los Angeles, CA, ³Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles, CA, ⁴Department of Surgery, University of Southern California, Los Angeles, CA
*Purpose: To compare Hispanic and non-Hispanic living liver donor candidates who were declined by a multidisciplinary selection committee at a large urban transplant center.*Methods: The…
2022 American Transplant Congress
Variation in Definition of Death in Donation After Circulatory Death Policies
D. Cassidy¹, M. J. Englesbe², V. S. Valbuena²
¹University of Michigan Medical School, Ann Arbor, MI, ²Department of Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Organ transplantation operates through a shared network requiring organizations, hospitals, and individuals to work towards a common goal. However, the policies that govern each…
2022 American Transplant Congress
Safety and Efficacy of Early Central Line Removal in Post Liver Transplant Patients
T. Shamaa¹, E. MacLean¹, O. Shamaa², Z. Lu¹, A. Hinge³, S. Saymuah³, A. Mohamed⁴, T. Kitajima⁴, S. Nagai⁴, M. Rizzari⁴, A. Yoshida⁴, M. Abouljoud⁴, K. Collins⁴
¹General Surgery, Henry Ford Hospital, Detroit, MI, ²Internal Medicine, Henry Ford Hospital, Detroit, MI, ³Wayne State University School of Medicine, Detroit, MI, ⁴Henry Ford Transplant Institute, Detroit, MI
*Purpose: Avoiding central line-associated infections (CLABSIs) is paramount in liver transplant recipients. As a hospital-wide infection control initiative at our institution, early removal of central…
2022 American Transplant Congress
PACAP-Mediated Autophagy Prevents Liver Ischemia Reperfusion Injury in OLT
Z. Xue, B. Yang, R. Busuttil, J. Kupiec-Weglinski, H. Ji
UCLA Medical Center, Los Angeles, CA
*Purpose: Pituitary adenylate cyclase-activating polypeptide (PACAP) is from vasoactive intestinal peptide-glucagon-secretin family. Our group was the first to demonstrate that neuropeptide PACAP, which innervates the…
2022 American Transplant Congress
A Successful Expansion of Donor Liver Supply is Feasible with the Selective Use of Older DCD Livers
M. Finotti, M. Rosenzweig, A. Wall, S. H. Lee, A. Gupta, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. Testa, G. J. McKenna
Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
*Purpose: DCD are a key way to expand the donor pool, yet many centers are hesitant about using anything but the most favorable DCD allografts,…
2022 American Transplant Congress
Race Inequity in Liver Transplant Waitlisting: Effect Modification by Psychosocial Factors and the Stanford Integrated Psychosocial Assessment for Transplant
S. Deutsch-Link¹, L. Nephew², E. Weinberg³, R. Weinrieb⁴, M. Serper³
¹Gastroenterology & Hepatology, University of North Carolina, Chapel Hill, NC, ²Gastroenterology & Hepatology, Indiana University, Chapel Hill, NC, ³Gastroenterology & Hepatology, University of Pennsylvania, Philadelphia, PA, ⁴Psychiatry, University of Pennsylvania, Philadelphia, PA
*Purpose: Race inequity in liver transplantation (LT) has been a longstanding area of injustice within the field of hepatology. Information from psychosocial evaluations and The…
2022 American Transplant Congress
Experience Using Intra-Operative Dialysis in Surgically Complex Liver Transplantation
M. Palascak¹, D. Arango¹, S. Yockelson¹, J. Koveleskie¹, D. Ganier¹, A. Cohen², H. Bohorquez²
¹Anesthesiology, Ochsner, New Orleans, LA, ²Surgery, Ochsner, New Orleans, LA
*Purpose: At our high-volume center, we often perform liver transplantation (LT) on surgically complex patients that includes re-transplantation, prior open liver resection, bariatric surgeries, extensive…
2022 American Transplant Congress
A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates
B. V. Tran¹, W. Lapisatepun¹, W. Dumronggittigule¹, D. Markovic², Y. Lee¹, F. Kaldas¹, D. Farmer¹, R. Busuttil¹, V. Agopian¹
¹Department of Surgery, University of California Los Angeles, Los Angeles, CA, ²Department of Medicine, Statistics Core, University of California Los Angeles, Los Angeles, CA
*Purpose: The current liver transplantation (LT) selection paradigm for hepatocellular carcinoma (HCC) patients ignores the variable risks of waitlist dropout and post-LT recurrence/death, with the…